This is unpublished


Physician & Research Faculty
Associate Professor, Division of Hematology and Oncology, University of Washington
Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Center
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.D., Virginia Commonwealth University  
  • M.S. in Physiology and Biophysics, Georgetown University 
  • Residency, Albert Einstein College of Medicine 
  • Fellowship in Oncology, Stanford University 
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine 

Clinical Expertise

  • Breast cancer



Research and/or clinical interests  

Dr. Shaveta Vinayak a medical oncologist who specializes in the treatment of breast cancer. Her research is focused on an aggressive subtype known as triple-negative breast cancer, which tends to affect younger people and those with a BRCA1 gene mutation. She designs and leads clinical trials that explore targeted therapies like immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells, and PARP inhibitors, a type of drug that may prevent cancer cells from fixing the damage caused by chemotherapy. PARP inhibitors may hold particular promise for people with BRCA-related cancers. In addition to treating patients and conducting research, Dr. Vinayak also leads education seminars about triple-negative breast cancer for African American women, who are three times more likely to be diagnosed with this form of cancer than women of other ethnicities.